Clinical impact of TP53 alterations in adrenocortical carcinomas

Langenbeck's Archives of Surgery

Volumn 397, Issue 2, 2012, Pages 209-216

  Waldmann, Jens ^a   Patsalis, Nikolaos ^a,b   Fendrich, Volker ^a   Langer, Peter ^a   Saeger, Wolfgang ^c   Chaloupka, Brunhilde ^a   Ramaswamy, Annette ^a   Fassnacht, Martin ^d   Bartsch, Detlef K ^a   Slater, Emily P ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c Marienkrankenhaus ^*  (Germany)

^d UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Adrenal cancer; Adrenalectomy; Adrenocortical cancer; TP53

Indexed keywords

KI 67 ANTIGEN; MITOTANE; PROTEIN P53;

ADOLESCENT; ADRENAL CORTEX CARCINOMA; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURGERY; CLINICAL ARTICLE; COHORT ANALYSIS; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DISEASE FREE SURVIVAL; EXON; FAMILY HISTORY; FEMALE; FOLLOW UP; GENETIC SCREENING; GERMLINE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOMATIC MUTATION; TISSUE SECTION;

ADOLESCENT; ADRENAL CORTEX NEOPLASMS; ADRENALECTOMY; ADRENOCORTICAL CARCINOMA; ADULT; AGED; COHORT STUDIES; DISEASE-FREE SURVIVAL; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GENETIC TESTING; GERM-LINE MUTATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84858866464     PISSN: 14352443     EISSN: 14352451     Source Type: Journal    
DOI: 10.1007/s00423-011-0868-6     Document Type: Article

References (26)

1. Wajchenberg BL, Albergaria Pereira MA, Medonca BB, Latronico AC, Campos Carneiro P, Alves VA, Zerbini MC, Liberman B, Carlos Gomes G, Kirschner MA (2000) Adrenocortical carcinoma: clinical and laboratory observations. Cancer 88(4):711-736 (Pubitemid 30091090)
2. Icard P, Goudet P, Charpenay C, Andreassian B, Carnaille B, Chapuis Y, Cougard P, Henry JF, Proye C (2001) Adrenocortical carcinomas: surgical trends and results of a 253-patient seriesfrom the French Association of Endocrine Surgeons study group. World J Surg 25(7):891-897 (Pubitemid 32666390)
3. Vassilopoulou-Sellin R, Schultz PN (2001) Adrenocortical carcinoma. Clinical outcome at the end of the 20th century. Cancer 92 (5):1113-1121 (Pubitemid 32861659)
4. Velazquez-Fernandez D, Laurell C, Geli J, Hoog A, Odeberg J, Kjellman M, Lundeberg J, Hamberger B, Nilsson P, Backdahl M (2005) Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy. Surgery 138(6):1087-1094 (Pubitemid 41797349)
5. Slater EP, Diehl SM, Langer P, Samans B, Ramaswamy A, Zielke A, Bartsch DK (2006) Analysis by cDNA microarrays of gene expression patterns of human adrenocortical tumors. Eur J Endocrinol 154(4):587-598
6. Giordano TJ, Thomas DG, Kuick R, Lizyness M, Misek DE, Smith AL, Sanders D, Aljundi RT, Gauger PG, Thompson NW, Taylor JM, Hanash SM (2003) Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis. Am J Pathol 162(2):521-531 (Pubitemid 36267859)
7. Hatada I, Ohashi H, Fukushima Y, Kaneko Y, Inoue M, Komoto Y, Okada A, Ohishi S, Nabetani A, Morisaki H, Nakayama M, Niikawa N, Mukai T (1996) An imprinted gene p57KIP2 is mutated in Beckwith-Wiedemann syndrome. Nat Genet 14(2):171-173 (Pubitemid 26338797)
8. Birch JM, Alston RD, McNally RJ, Evans DG, Kelsey AM, Harris M, Eden OB, Varley JM (2001) Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 20(34):4621-4628 (Pubitemid 32762434)
9. Hisada M, Garber J, Fung CY, Fraumeni JF Jr, Li FP (1998) Multiple primary cancers in families with Li-Fraumeni Syndrome. J Natl Cancer Inst 90:7622-7627
10. Gicquel C, Bertagna X, Gaston V, Coste J, Louvel A, Baudin E, Bertherat J, Chapuis Y, Duclos JM, Schlumberger M, Plouin PF, Luton JP, Le Bouc Y (2001) Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. Cancer Res 61(18):6762-6767 (Pubitemid 32896498)
11. Libe R, Groussin L, Tissier F, Elie C, Rene-Corail F, Fratticci A, Jullian E, Beck-Peccoz P, Bertagna X, Gicquel C, Bertherat J (2007) Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity. Clin Cancer Res 13(3):844-850 (Pubitemid 46340358)
12. Reincke M, Karl M, Travis WH, Mastorakos G, Allolio B, Linehan HM, Chrousos GP (1994) p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies. J Clin Endocrinol Metab 78(3):790-794
13. Sidhu S, Martin E, Gicquel C, Melki J, Clark SJ, Campbell P, Magarey CJ, Schulte KM, Roher HD, Delbridge L, Robinson BG (2005) Mutation and methylation analysis of TP53 in adrenal carcinogenesis. Eur J Surg Oncol 31(5):549-554 (Pubitemid 40724098)
14. van Slooten H, Schaberg A, Smeenk D, Moolenaar AJ (1985) Morphologic characteristics of benign and malignant adrenocortical tumors. Cancer 55:766-773 (Pubitemid 15173514)
15. Weiss LM, Medeiros LJ, Vickery AL Jr (1989) Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 13(3):202-206 (Pubitemid 19081702)
16. Waldmann J, Feldmann G, Slater EP, Langer P, Buccholz M, Ramaswamy A, Saeger W, Rothmund M, Fendrich V (2008) Expression of the zinc-finger transcription factor Snail in adrenocortical carcinoma is associated with decreased survival. Br J Cancer 99:1900-1907
17. Barzon L, Chilosi M, Fallo F, Martignoni G, Montagna L, Palu G, Boscaro M (2001) Molecular analysis of CDKN1C and TP53 in sporadic adrenal tumors. Eur J Endocrinol 145 (2):207-212 (Pubitemid 32707608)
18. Sidhu S, Marsh DJ, Theodosopoulos G, Philips J, Bambach CP, Campbell P, Magarey CJ, Russell CF, Schulte KM, Roher HD, Delbridge L, Robinson BG (2002) Comparative genomic hybridization analysis of adrenocortical tumors. J Clin Endocrinol Metab 87(7):3467-3474 (Pubitemid 34816405)
19. Ohgaki H, Kleihues P, Heitz PU (1993) p53 mutations in sporadic adrenocortical tumors. Int J Cancer 54(3):408-410 (Pubitemid 23169678)
20. Libe R, Bertherat J (2005) Molecular genetics of adrenocortical tumours, from familial to sporadic diseases. Eur J Endocrinol 153 (4):477-487 (Pubitemid 41568145)
21. Arola J, Salmenkivi K, Liu J, Kahri AI, Heikkila P (2000) p53 and Ki67 in adrenocortical tumors. Endocr Res 26(4):861-865 (Pubitemid 32053112)
22. McNicol AM, Nolan CE, Struthers AJ, Farquharson MA, Hermans J, Haak HR (1997) Expression of p53 in adrenocortical tumours: clinicopathological correlations. J Pathol 181 (2):146-152 (Pubitemid 27087277)
23. Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P, Olivier M (2007) Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat 28(6):622-629 (Pubitemid 46744292)
24. Bourdon JC, D'Errico A, Paterlini P, Grigioni W, May E, Debuire B (1995) p53 protein accumulation in European hepatocellular carcinoma is not always dependent on p53 gene mutation. Gastroenterology 108(4):1176-1182
25. Moll UM, Riou G, Levine AJ (1992) Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci U S A 89(15):7262-7266
26. Bookstein R, MacGrogan D, Hilsenbeck SG, Sharkey F, Allred DC (1993) p53 is mutated in a subset of advanced-stage prostate cancers. Cancer Res 53:3369-3373 (Pubitemid 23223311)